Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Clin Lymphoma Myeloma Leuk ; 15 Suppl: S19-26, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-26297273

RESUMEN

The present report focuses on management strategies for the myeloproliferative neoplasm according to the structure and processes we use within our center, a large tertiary unit in central London. The standard procedures for achieving an accurate diagnosis and risk stratification and therapeutic strategies for these diseases with a detailed focus on contentious areas are discussed. In the 9 years after the description of the Janus kinase 2 mutation, this field has altered quite radically in several aspects. For example, a new therapeutic paradigm exists, especially for myelofibrosis. We share how our unit has adapted to these changes.


Asunto(s)
Trastornos Mieloproliferativos/terapia , Humanos , Trastornos Mieloproliferativos/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...